SCHEMBL21882072

SCHEMBL21882072

OCCOc1ccc(Cl)c(F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.49
PRKAB2 O43741 1/20 0.48
PRKAG1 P54619 1/20 0.48
PRKAA2 P54646 1/20 0.48
PRKAA1 Q13131 1/20 0.48
PRKAG3 Q9UGI9 1/20 0.48
PRKAG2 Q9UGJ0 1/20 0.48
PRKAB1 Q9Y478 1/20 0.48
ATF4 P18848 5/20 0.46
ALDH1A1 P00352 1/20 0.44
RECQL P46063 1/20 0.44
HTR1A P08908 1/20 0.44
HTR7 P34969 1/20 0.44
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43
TP53 P04637 1/20 0.43
GAA P10253 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43
FFAR4 Q5NUL3 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25215479 0.91 GPR84 (0.49) GPR84SMN1; SMN2PRKAB2PRKAG1PRKAA2
SCHEMBL2094457 0.85 ATF4 (0.48) GPR84SMN1; SMN2ATF4PPARGPPARA
SCHEMBL3525094 0.83 GPR84 (0.51) GPR84ATF4PPARGPPARAHRH3
SCHEMBL9451250 0.82 SMN1; SMN2 (0.67) GPR84SMN1; SMN2ALDH1A1RECQLTP53
SCHEMBL21490294 0.82 MAOB (0.49) SMN1; SMN2PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL29450668 0.82 SMN1; SMN2 (0.67) GPR84SMN1; SMN2ALDH1A1RECQLTP53
SCHEMBL30368255 0.82 MAOB (0.49) SMN1; SMN2PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL17433278 0.81 GPR84 (0.50) GPR84ATF4ALDH1A1RECQLHTR1A
SCHEMBL95960 0.81 GPR84 (0.50) GPR84SMN1; SMN2ATF4HTR1AHTR7
Hydrochloric Acid SCHEMBL15512062 0.81 GPR84 (0.50) GPR84SMN1; SMN2ATF4PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11166942-B2 Inhibitors of integrated stress response pathway Praxis Biotech LLC (US) 2021-11-09 US disclosed
US-20200101047-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY Praxis Biotech LLC 2020-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11166942-B2 Inhibitors of integrated stress response pathway ATF4, DDIT3, ATF1 GPR84 3616/4885SMN1; SMN2 3465/4885PRKAB2 239/4885
US-20200101047-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ATF4, DDIT3, ATF1 GPR84 3616/4885SMN1; SMN2 3465/4885PRKAB2 239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.